Combination Therapy for the Treatment of Cutaneous Leishmaniasis Compared with Standard Drugs, In Vitro or In Vivo: A Systematic Review
Advanced Biomedical Research · 2025-11 · 14 (1)
DOI: 10.4103/abr.abr_17_24 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Biomedical Research, 2025-11. Verfasst von Parisa Mousavi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The obligate intracellular parasite, Leishmania, causes leishmaniasis as an infectious disease. The parasite is transmitted through female sandfly bites and infects the host mononuclear phagocytes, leading to severe skin lesions and fatal systemic infection. The quick diagnosis and effective treatment can prevent the development scars and chronic or uncontrollable disease forms. The current chemical and physical treatments have limitations; hence, the use of plant compounds and their derivatives is a new proposed treatment method. Therefore, in this review, the recent advances in combination therapy of cutaneous leishmaniasis were investigated. The information was obtained from all articles published in PubMed, SciELO, ScienceDirect, Scopus, Google Scholar, and Web of Science databases (1998–2022). Search terms used were “Combination Therapy” AND “Cutaneous Leishmaniasis.” The data showed increased synergistic efficacy or shortening the course of treatment and few adverse effects in the combined treatment of (CL), in vitro and in vivo . Expanding the combination therapy in clinical trials could open a new insight in treatment strategies of CL.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
- Environment Research Center, Research Institute for Primordial Prevention of Non-communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran.
- Skin Diseases and Leishmaniasis Research Center, Department of Dermatology, Isfahan University of Medical Sciences, Isfahan, Iran.
- Skin Diseases and Leishmaniasis Research Center, Department of Parasitology and Mycology, Isfahan University of Medical Sciences, Isfahan, Iran.
Zitieren
APA
Mousavi, P., Zolfaghari, A., Aghaei, M., Heidari, A., Shahmoradi, Z., & Hejazi, S. H. (2025). Combination Therapy for the Treatment of Cutaneous Leishmaniasis Compared with Standard Drugs, In Vitro or In Vivo: A Systematic Review. Advanced Biomedical Research, 14(1). https://doi.org/10.4103/abr.abr_17_24
Vancouver
Mousavi P, Zolfaghari A, Aghaei M, Heidari A, Shahmoradi Z, Hejazi SH. Combination Therapy for the Treatment of Cutaneous Leishmaniasis Compared with Standard Drugs, In Vitro or In Vivo: A Systematic Review. Advanced Biomedical Research. 2025;14(1). doi:10.4103/abr.abr_17_24
BibTeX
@article{Mousavi2025,
author = {Mousavi, Parisa and Zolfaghari, Azadeh and Aghaei, Maryam and Heidari, Asieh and Shahmoradi, Zabihollah and Hejazi, Seyed Hossein},
title = {Combination Therapy for the Treatment of Cutaneous Leishmaniasis Compared with Standard Drugs, In Vitro or In Vivo: A Systematic Review},
journal = {Advanced Biomedical Research},
year = {2025},
volume = {14},
number = {1},
doi = {10.4103/abr.abr_17_24}
}
EUVIMED